FOP News

Important Press Release and Letter from Ipsen Announcing They Will Reinitiate Dosing in the MOVE Trial

Dosing to begin again in patients 14 years of age and older currently enrolled in the trial

Read more Share

STOPFOP Recruitment Paused

Read more Share

International Clinical Council on FOP Issues COVID-19 Precautions for FOP Families

Read more Share

Coronavirus (COVID-19) Precautions for FOP Families (Updated March 13, 2020)

Read more Share

What Should FOP Families Do to Protect Against Coronavirus?

Read more Share

Launch of a New Phase 2 Clinical Trial “STOPFOP”

Read more Share

University of Michigan Publishes Article Identifying Different Immune Cell Types Post Injury

Read more Share

Important Announcement and Letter from Ipsen Regarding the MOVE Trial and a Pause in Dosing

Read more Share

Regeneron Releases Phase 2 Trial Results and Shares Next Steps

Read more Share

Regeneron Pharmaceutical Releases Results of Phase 2 of the LUMINA-1 Trial

Read more Share

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter